USCOM Ltd (ASX: UCM) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
USCOM Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$7.81 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
190.53 million
Earnings per share
-0.015
Dividend per share
N/A
Year To Date Return
-8.89%
Earnings Yield
N/A
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
USCOM Ltd (ASX: UCM)
Latest News
Healthcare Shares
The Uscom (ASX:UCM) share price plunged 6% today. Here's why
Share Gainers
These ASX shares are fighting the spread of coronavirus
Share Gainers
Why this small-cap ASX healthcare share surged 39% higher today
UCM ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About USCOM Ltd
USCOM Ltd is engaged in the development, design, manufacture, and marketing of premium non-invasive cardiovascular and pulmonary medical devices. The company's geographical segment includes Australia, Asia, America, Europe, and Other regions. It generates maximum revenue from Australia. The company offers USCOM 1A, a non-invasive hemodynamic monitor that measures cardiovascular function; BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, SPIROSONIC, a pulmonary function testing device based on multi-path ultrasound technology and the VENTITEST and VENTITEST-S ultrasonic ventilator calibration devices for optimizing respiratory device performance.
UCM Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 27 Nov 2023 | $0.04 | $0.00 | 0.00% | 46,464 | $0.04 | $0.04 | $0.04 |
| 23 Nov 2023 | $0.04 | $0.00 | 0.00% | 23,780 | $0.04 | $0.04 | $0.04 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 26 Oct 2023 | Robert Phillips | Issued | 4,756,891 | $233,087 |
Issue of securities. 4,756,891 performance rights
|
| 07 Jul 2023 | Robert Phillips | Buy | 3,164,557 | $148,734 |
Conversion of securities. As per announcement on 07-07-2022
There is no transaction reported for conversion of rights. |
| 12 Apr 2023 | Robert Phillips | Buy | 569,302 | $25,618 |
Off-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Brett Thomas Crowley | Company SecretaryNon Executive director | May 2016 |
Mr Crowley is a former Partner of Ernst & Young in Hong Kong and Australia, and of KPMG in Hong Kong, and has worked in China establishing and managing JV companies there. Mr Crowley is a chairman, finance director and company secretary of ASX-listed companies and is a former Senior Legal Member of the NSW Civil and Administrative Tribunal.
|
| Mr Robert Allan Phillips | Chief Executive OfficerExecutive ChairmanExecutive Director | Nov 2011 |
Mr Phillips has 20 years of experience in corporate management since taking Uscom public in 2003 and has taken the company global with regional headquarters in Singapore, Beijing and Budapest with offices in Delawere.
|
| Mr Christian R Bernecker | Non-Executive Director | Nov 2011 |
Mr Bernecker has more than 10 years of investment experience across capital raising, acquisitions and divestments.
|
| Mr Xianhui Meng | Non-Executive Director | Dec 2019 |
Mr Meng is an international value investor. Mr Meng has 10 years of experience as a China government departmental head, and 20 years of experience as the Executive Manager and Executive Director of a HK Listed Chinese Pharma specializing in sales and distribution. Mr Meng brings both his international corporate management and strategic skills to the Uscom Board.
|
| Nick Schicht | General Manager |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Mr Robert Allan Phillips | 46,664,635 | 24.49% |
| Citicorp Nominees Pty Limited | 42,985,397 | 22.56% |
| Jetan Pty Ltd | 13,637,064 | 7.16% |
| HSBC Custody Nominees (Australia) Limited | 8,539,336 | 4.48% |
| Jetan Pty Ltd <G R Plummer Super Fund A/C> | 6,500,000 | 3.41% |
| Invia Custodian Pty Limited <Bozwald Pty Ltd A/C> | 3,289,168 | 1.73% |
| Mr David Leroy Boyles | 3,000,000 | 1.58% |
| Ms Pamela Jack | 2,845,212 | 1.49% |
| Invia Custodian Pty Limited <Riverbel Family No 3 A/C> | 2,714,554 | 1.42% |
| Mr Dongjun Sun | 2,414,125 | 1.27% |
| Mr Douglas James Cameron | 2,375,099 | 1.25% |
| Mrs Christine Quye | 2,311,227 | 1.21% |
| Mr Rutherford James Browne & Mrs Sheba Elizabeth Marjorie Browne | 2,121,991 | 1.11% |
| Mr Perry Julian Rosenzweig | 1,820,711 | 0.96% |
| Mr Christopher James Were & Lockhart Trustee Services No 17 Limited | 1,424,095 | 0.75% |
| Trentham Super Pty Ltd <Trentham Sf A/C> | 1,351,000 | 0.71% |
| Mr Dean Leon Burrows & Mrs Kerry Ann Burrows | 1,100,000 | 0.58% |
| Mak Planning And Design Pty Ltd <S Alston Superannuation A/C> | 1,087,001 | 0.57% |
| Nintieth Y Pty Ltd <I K Caldwell & Co Staff A/C> | 1,075,000 | 0.56% |
| Pither Investments Pty Ltd <Pither Investments A/C> | 1,075,000 | 0.56% |
